{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477235914
| IUPAC_name = 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone
| image = AM-694-2D-skeletal.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = S9
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Schedule I
| legal_DE = Anlage II
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 335161-03-0
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 9889172
| ChEBI = 138017
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8064843

<!--Chemical data-->
| C=20 | H=19 | F=1 | I=1 | N=1 | O=1 
| molecular_weight = 435.273 g/mol
| smiles = Ic2ccccc2C(=O)c1cn(CCCCCF)c3ccccc13
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H19FINO/c21-12-6-1-7-13-23-14-17(15-8-3-5-11-19(15)23)20(24)16-9-2-4-10-18(16)22/h2-5,8-11,14H,1,6-7,12-13H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LFFIIZFINPPEMC-UHFFFAOYSA-N
}}
{{More footnotes|date=May 2011}}
'''AM-694''' (1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole) is a drug that acts as a potent and selective [[agonist]] for the [[cannabinoid receptor]] [[Cannabinoid receptor 1|CB<sub>1</sub>]]. It is used in scientific research for mapping the distribution of CB<sub>1</sub> receptors. No public data about AM-694 [[metabolism]] is known{{Citation needed|date=July 2012}}. AM-694 has already emerged as a [[designer drug]].

==Pharmacology==
AM-694 is an [[agonist]] for [[cannabinoid receptor]]s. Affinities are: with a [[Dissociation constant|''K''<sub>i</sub>]] of 0.08&nbsp;nM at [[Cannabinoid receptor 1|CB<sub>1</sub>]] and 18x selectivity over [[Cannabinoid receptor 2 (macrophage)|CB<sub>2</sub>]] with a ''K''<sub>i</sub> of 1.44&nbsp;nM.<ref name="WO 2001 28557 A1">{{Ref patent2 | country = WO | number = 200128557 | status = granted | title = Cannabimimetic indole derivatives | pubdate = 2001-04-26 | gdate = 2001-06-07 | pridate= 1999-10-18 | inventor = Makriyannis A, Deng H | assign1= }}</ref> It is unclear what is responsible for this unusually high CB<sub>1</sub> binding affinity, but it makes the [[fluorine-18|<sup>18</sup>F]] [[Isotopic labeling|radiolabelled]] derivative of AM-694 useful for mapping the distribution of CB<sub>1</sub> receptors in the body.<ref>Willis PG, Katoch-Rouse R, Horti AG. Regioselective F-18 radiolabeling of AM694, a CB1 cannabinoid receptor ligand. ''Journal of Labelled Compounds and Radiopharmaceuticals'' 2003;46(9):799-804. {{doi|10.1002/jlcr.720}}</ref>

===Pharmacokinetics===
{{Refimprove section|date=July 2012}}
{{Main|JWH-018#Pharmacokinetics|l1=Pharmacokinetic data of JWH-018 are generally applicable to AM-694.}}
AM-694 [[metabolism]] differs only slightly from that of [[JWH-018]]. AM-694 ''N''-[[dealkylation]] produces fluoropentane instead of [[pentane]] (or plain [[alkane]]s in general). It has been speculated that the fluoropentane might function as an [[alkylating agent]] or is further metabolized into toxic [[fluoroacetic acid]]. This is not true since [[fluoroalkane]]s do not act as [[alkylating agent]]s under normal conditions and uneven [[fluoroalkane]] chains metabolize into substantially less toxic [[fluoropropanoic acid]].<ref>[https://wayback.archive-it.org/all/20120227014952/http://article.pubs.nrc-cnrc.gc.ca/ppv/RPViewDoc?issn=1480-3291&volume=34&issue=11&startPage=1532 Millington JE, Pattison FLM. TOXIC FLUORINE COMPOUNDS: XII. ESTERS OF ω-FLUOROALCOHOLS. ''Canadian Journal of Chemistry''. 1956 Nov;34(11):1532-1541.]</ref><ref>[https://wayback.archive-it.org/all/20120227015004/http://article.pubs.nrc-cnrc.gc.ca/ppv/RPViewDoc?issn=1480-3291&volume=35&issue=2&startPage=141 Pattison FLM, Howell WC, Woolford RG. TOXIC FLUORINE COMPOUNDS: XIII. ω-FLUOROALKYL ETHERS. ''Canadian Journal of Chemistry''. 1957 Feb;35(2):141-148.]</ref>

==See also==
* [[AM-679 (cannabinoid)|AM-679]]
* [[AM-1235]]
* [[AM-2201]]
* [[AM-2232]]
* [[AM-2233]]
* [[FUBIMINA]]
* [[JWH-018]]
* [[List of AM cannabinoids]]
* [[List of JWH cannabinoids]]
* [[THJ-2201]]

==References==
<references/>

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Benzoylindoles]]
[[Category:Iodoarenes]]
[[Category:Fluoroalkanes]]
[[Category:AM cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indoles]]